Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
A Survey for Factors That Influence Postoperative Treatment Decision-making for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
P1101 and Anti-PD1 for After Curative Surgery of Hepatitis B-related Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
BioPearlâ„¢ Microspheres Loaded With Doxorubicin: Prospective, Single Arm, Multi-centre Post-market Follow-up Study.
- Status
- WITHDRAWN
- Phase
- NA
DEB-TACE Plus Lenvatinib or Sorafenib or PD-1 Inhibitor for Unresectable Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Longitudinal Immune-phenotyping of HCC Following MK-3475
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC
- Status
- UNKNOWN
- Phase
- N/A
Epigenetic Changes in Hepatocellular Carcinoma Developed After Direct Acting Antiviral Therapy for Chronic Hepatitis C
- Status
- UNKNOWN
- Phase
- N/A
Anlotinib Combined With TACE in Hepatocellular Carcinoma Patients at High Risk of Post Surgery Recurrence
- Status
- UNKNOWN
- Phase
- PHASE2
Interest of the Intervention of a Nurse Coordinator in Complex Care Pathway
- Status
- UNKNOWN
- Phase
- N/A
Cabozantinib to Treat Recurrent Liver Cancer Post Transplant
- Status
- RECRUITING
- Phase
- PHASE2
Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC)
- Status
- UNKNOWN
- Phase
- PHASE2
Sleep Apnoea Syndrome and Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- N/A
Discrepancies in Management of Hepatocellualr Carcinoma Between Practice and Recommendations
- Status
- UNKNOWN
- Phase
- N/A
LITT and Pembrolizumab in Recurrent Brain Metastasis
- Status
- TERMINATED
- Phase
- PHASE1